Norris Perne & French LLP MI increased its stake in shares of Stericycle Inc. (NASDAQ:SRCL) by 51.2% during the second quarter, Holdings Channel reports. The institutional investor owned 62,180 shares of the company’s stock after buying an additional 21,060 shares during the period. Stericycle comprises approximately 1.4% of Norris Perne & French LLP MI’s holdings, making the stock its 29th largest position. Norris Perne & French LLP MI owned 0.07% of Stericycle worth $6,474,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. Norges Bank bought a new position in Stericycle during the fourth quarter valued at about $76,432,000. Chevy Chase Trust Holdings Inc. increased its position in Stericycle by 5.2% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 74,656 shares of the company’s stock valued at $9,421,000 after buying an additional 3,659 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund increased its position in Stericycle by 15.6% in the first quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 16,521 shares of the company’s stock valued at $2,085,000 after buying an additional 2,227 shares in the last quarter. Exxonmobil Investment Management Inc. TX increased its position in Stericycle by 8.6% in the first quarter. Exxonmobil Investment Management Inc. TX now owns 20,692 shares of the company’s stock valued at $2,611,000 after buying an additional 1,643 shares in the last quarter. Finally, GW&K Investment Management LLC increased its position in Stericycle by 26.1% in the first quarter. GW&K Investment Management LLC now owns 74,373 shares of the company’s stock valued at $9,385,000 after buying an additional 15,402 shares in the last quarter. Institutional investors own 92.81% of the company’s stock.

Shares of Stericycle Inc. (NASDAQ:SRCL) traded down 3.99% on Monday, reaching $78.00. 2,361,382 shares of the company’s stock were exchanged. The company has a market capitalization of $6.63 billion, a P/E ratio of 27.46 and a beta of 0.27. Stericycle Inc. has a 1-year low of $77.00 and a 1-year high of $151.57. The stock’s 50-day moving average price is $85.11 and its 200-day moving average price is $102.87.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings results on Thursday, July 28th. The company reported $1.18 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.18. The company earned $891.60 million during the quarter, compared to analyst estimates of $910.29 million. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. The business’s revenue for the quarter was up 24.6% compared to the same quarter last year. During the same period in the prior year, the business posted $1.14 EPS. Analysts anticipate that Stericycle Inc. will post $4.67 EPS for the current fiscal year.

SRCL has been the subject of several recent research reports. Imperial Capital decreased their target price on shares of Stericycle from $100.00 to $95.00 and set an “in-line” rating for the company in a research note on Thursday, May 26th. Royal Bank Of Canada reiterated a “sell” rating on shares of Stericycle in a research note on Thursday, May 26th. Zacks Investment Research downgraded shares of Stericycle from a “hold” rating to a “sell” rating in a research note on Tuesday, June 28th. Jefferies Group reiterated a “buy” rating and set a $140.00 target price on shares of Stericycle in a research note on Monday, July 18th. Finally, Wellington Shields downgraded shares of Stericycle from an “accumulate” rating to a “hold” rating in a research note on Friday, July 29th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $110.32.

In related news, Director Mark C. Miller sold 34,835 shares of the business’s stock in a transaction that occurred on Friday, July 8th. The shares were sold at an average price of $104.52, for a total value of $3,640,954.20. Following the sale, the director now directly owns 244,284 shares in the company, valued at approximately $25,532,563.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP John P. Schetz sold 1,398 shares of the business’s stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total transaction of $114,426.30. Following the completion of the sale, the executive vice president now owns 1,088 shares in the company, valued at $89,052.80. The disclosure for this sale can be found here. 3.30% of the stock is currently owned by insiders.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.